125 related articles for article (PubMed ID: 27468569)
1. Serum Sialic Acid Concentration and Content in ApoB-Containing Lipoproteins in Liver Diseases.
Gudowska M; Gruszewska E; Cylwik B; Panasiuk A; Filisiak R; Szmitkowski M; Chrostek L
Clin Lab; 2016; 62(6):1069-74. PubMed ID: 27468569
[TBL] [Abstract][Full Text] [Related]
2. Lipid-bound sialic acid (LSA) in liver diseases of different etiologies.
Chrostek L; Cylwik B; Panasiuk A; Brodowska-Adamusiak D; Gruszewska E
Ann Hepatol; 2011; 10(2):150-4. PubMed ID: 21502676
[TBL] [Abstract][Full Text] [Related]
3. Changed Profile of Serum Transferrin Isoforms in Liver Diseases.
Gudowska M; Gruszewska E; Panasiuk A; Cylwik B; Swiderska M; Filisiak R; Szmitkowski M; Chrostek L
Clin Lab; 2017 Feb; 63(2):349-354. PubMed ID: 28182352
[TBL] [Abstract][Full Text] [Related]
4. The changes of sialic acid concentration and content in apolipoprotein B-containing lipoproteins in the sera of alcoholics.
Cylwik B; Chrostek L; Brodowska-Adamusiak D; Gruszewska E; Daniluk M; Szmitkowski M
Alcohol Alcohol; 2010; 45(5):422-6. PubMed ID: 20663853
[TBL] [Abstract][Full Text] [Related]
5. The concentration of total sialic acid in chronic hepatitis B and C.
Gruszewska E; Cylwik B; Gudowska M; Panasiuk A; Flisiak R; Chrostek L
Ann Clin Biochem; 2019 Jan; 56(1):118-122. PubMed ID: 30027776
[TBL] [Abstract][Full Text] [Related]
6. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
[TBL] [Abstract][Full Text] [Related]
7. Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation.
Tietge UJ; Boker KH; Bahr MJ; Weinberg S; Pichlmayr R; Schmidt HH; Manns MP
Hepatogastroenterology; 1998; 45(24):2255-60. PubMed ID: 9951906
[TBL] [Abstract][Full Text] [Related]
8. [The behavior of lipids in acute viral hepatitis and chronic hepatopathies].
Boroń-Kaczmarska A; Lapiński W
Z Gesamte Inn Med; 1988 May; 43(9):225-8. PubMed ID: 3136599
[TBL] [Abstract][Full Text] [Related]
9. Plasma lipoprotein alterations in patients with chronic hepatocellular liver disease resulting from alcohol abuse: effects of alcohol intake cessation.
Camps J; Pizarro I; Prats E; La Ville A; Turner PR; Masana L; Joven J
J Hepatol; 1994 Nov; 21(5):704-9. PubMed ID: 7890883
[TBL] [Abstract][Full Text] [Related]
10. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
[TBL] [Abstract][Full Text] [Related]
11. A simple precipitation method for measuring sialic acid in apolipoprotein B-containing lipoproteins in plasma.
Shishino K; Yoshioka Y; Hashimoto K; Ochi M; Aono K; Murase M; Osawa H; Makino H; Saheki S
Ann Clin Biochem; 2005 Jul; 42(Pt 4):298-300. PubMed ID: 15989730
[TBL] [Abstract][Full Text] [Related]
12. The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins.
Chrostek L; Supronowicz L; Panasiuk A; Cylwik B; Gruszewska E; Flisiak R
Clin Exp Med; 2014 Nov; 14(4):417-21. PubMed ID: 24122348
[TBL] [Abstract][Full Text] [Related]
13. Lipoproteins, HDL-apolipoproteins, activities of hepatic lipase and lecithin-cholesterol acyltransferase in the plasma of patients with post-alcoholic end-stage liver cirrhosis.
Breier C; Lisch HJ; Braunsteiner H
Klin Wochenschr; 1983 Sep; 61(18):929-31. PubMed ID: 6632732
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease.
Elefsiniotis IS; Skounakis M; Vezali E; Pantazis KD; Petrocheilou A; Pirounaki M; Papatsibas G; Kontou-Kastellanou C; Moulakakis A
Eur J Gastroenterol Hepatol; 2006 May; 18(5):525-30. PubMed ID: 16607149
[TBL] [Abstract][Full Text] [Related]
15. Selected Noninvasive Markers in Diagnosing Liver Diseases.
Gudowska M; Gruszewska E; Panasiuk A; Cylwik B; Świderska M; Flisiak R; Szmitkowski M; Chrostek L
Lab Med; 2016 Feb; 47(1):67-72. PubMed ID: 26715612
[TBL] [Abstract][Full Text] [Related]
16. [Usefulness of sialic acid determination to differentiation between alcohol abuse and alcoholic liver cirrhosis].
Cylwik B; Brodowska D; Chrostek L; Panasiuk A; Szmitkowski M
Pol Merkur Lekarski; 2009 Nov; 27(161):368-71. PubMed ID: 19999798
[TBL] [Abstract][Full Text] [Related]
17. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
18. Serum hyaluronate in liver diseases: study by enzymoimmunological assay.
Frébourg T; Delpech B; Bercoff E; Senant J; Bertrand P; Deugnier Y; Bourreille J
Hepatology; 1986; 6(3):392-5. PubMed ID: 3710427
[TBL] [Abstract][Full Text] [Related]
19. Plasma lipoprotein and apolipoprotein profile in alcoholic patients with and without liver disease: on the relative roles of alcohol and liver injury.
Duhamel G; Nalpas B; Goldstein S; Laplaud PM; Berthelot P; Chapman MJ
Hepatology; 1984; 4(4):577-85. PubMed ID: 6430773
[TBL] [Abstract][Full Text] [Related]
20. Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2.
Dashti N; Alaupovic P; Knight-Gibson C; Koren E
Biochemistry; 1987 Jul; 26(15):4837-46. PubMed ID: 2822101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
